PhD · Katholieke Universiteit Leuven · company speakers →
Dr. Karen Vanhoorelbeke will discuss the efficacy of N-acetyl cysteine (NAC) in the treatment of immune mediated thrombotic thrombocytopenia purpura (TTP) as tested in animal models. In addition, literature and clinical trials where NAC has been used to treat TTP patients will be reviewed. Finally, novel data on the role of anti-ADAMTS13 autoantibodies in immune-mediated TTP will be discussed.
Is this you? Claim this profile →
No public contact links on file.
Sourcing speakers for your event?
Browse the speaker directory →